Etymologia: Meningococcal Disease
نویسنده
چکیده
endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Euro Surveill. 2015;20:pii: 21186. http://dx.doi.org/10.2807/1560-7917. ES2015.20.28.21188 4. Tully J, Viner RM, Coen PG, Stuart JM, Zambon M, Peckham C, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006;332:445– 50. http://dx.doi.org/10.1136/bmj.38725.728472.BE 5. Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014;384:2123–31. http://dx.doi.org/10.1016/ S0140-6736(14)60842-4 6. Universities and Colleges Admissions Service. End of cycle report: UCAS analysis and research December 2015 [cited 2017 Apr 11]. https://www.ucas.com/file/43181/ download?token=lnUjPHdK 7. Ladhani SN, Waight PA, Ribeiro S, Ramsay ME. Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources. BMC Infect Dis. 2015;15:551. http://dx.doi.org/10.1186/s12879-015-1247-7 8. Ladhani SN, Campbell H, Parikh SR, Saliba V, Borrow R, Ramsay M. The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme—new challenges for public health. J Infect. 2015;71:611–4. http://dx.doi.org/10.1016/j.jinf.2015.09.035 9. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993;22:742–6. http://dx.doi.org/10.1093/ije/22.4.742 10. Public Health England. Preliminary vaccine coverage estimate for the urgent catch-up meningococcal ACWY (MenACWY) immunisation programme for England, January 2016. Heal Prot Rep 2016;10 [cited 2017 Apr 11]. https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/505478/hpr0916_ menACWY.pdf 11. Turner DP, Oldfield NJ, Bayliss CD. University vaccine campaign increases meningococcal ACWY vaccine coverage. Public Health. 2017;145:1–3. http://dx.doi.org/10.1016/j.puhe.2016.12.010 12. Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016;388:2775–82. http://dx.doi.org/10.1016/ S0140-6736(16)31921-3 13. Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, et al. Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W strain, England. Emerg Infect Dis. 2016;22:309–11. http://dx.doi.org/ 10.3201/eid2202.150369 14. Public Health England. Preliminary vaccine coverage for the school based meningococcal ACWY (MenACWY) adolescent vaccination programme in England, September 1, 2015 to August 31, 2016. Heal Prot Rep 2016;10 [cited 2017 Apr 11]. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/578772/ hpr4416_menacwy-vc.pdf 15. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:853–61. http://dx.doi.org/10.1016/S1473-3099(10)70251-6
منابع مشابه
Immunological Aspect of Meningococcal disease: An overview in Host- Bacteria Interaction
Meningococcal disease remains a significant global public health and is unique among causes of bacterial meningitis and sepsis where it not only causes sporadic disease but also outbreaks. Meningococcal disease has a rapid onset with high mortality. The understanding of immunopathogenesis is crucial for development of novel therapeutic strategies and vaccines designed against meningococcal dise...
متن کاملNeed for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programmes (NIPs). In 2002, the Netherlands successfully implemented a single dose of meningococcal serogroup C conjugate vaccine at the age of 14 months a...
متن کاملEndothelial cell adhesion molecules in meningococcal disease.
BACKGROUND Endothelial damage is important in meningococcal disease. Cell adhesion molecules, including P selectin, E selectin, and intercellular cell adhesion molecule 1 (ICAM-1), are expressed by activated endothelium and then subsequently shed. METHODS ICAM-1, P selectin, and E selectin were measured on admission to hospital in children with meningococcal infections. RESULTS Concentratio...
متن کاملHigh Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
Use of eculizumab (Soliris, Alexion Pharmaceuticals), a terminal complement inhibitor, is associated with a 1,000-fold to 2,000-fold increased incidence of meningococcal disease (1). Administration of meningococcal vaccines is recommended for patients receiving eculizumab before beginning treatment (2,3). Sixteen cases of meningococcal disease were identified in eculizumab recipients in the Uni...
متن کاملEpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination.
AIM To review the epidemiology of invasive meningococcal disease in NSW for the period 1991-2011, in particular since the introduction of the meningococcal C vaccination program in 2003. METHODS We undertook a descriptive analysis of NSW notifications of invasive meningococcal disease for the period 2003-2011, and explored long-term changes in the epidemiology of invasive meningococcal diseas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 23 شماره
صفحات -
تاریخ انتشار 2017